Hs Management Partners Has Lifted Its Hershey Co (HSY) Position; Sabby Management Continues to Hold Holding in Idera Pharmaceuticals (IDRA)

May 14, 2018 - By Darrin Black

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Logo

Hal Mintz increased its stake in Idera Pharmaceuticals Inc (IDRA) by 98.67% based on its latest 2017Q4 regulatory filing with the SEC. Sabby Management Llc bought 152,960 shares as the company’s stock declined 4.33% with the market. The hedge fund run by Hal Mintz held 307,987 shares of the health care company at the end of 2017Q4, valued at $650,000, up from 155,027 at the end of the previous reported quarter. Sabby Management Llc who had been investing in Idera Pharmaceuticals Inc for a number of months, seems to be bullish on the $409.63M market cap company. The stock increased 7.10% or $0.12 during the last trading session, reaching $1.88. About 1.09M shares traded. Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) has declined 21.96% since May 14, 2017 and is downtrending. It has underperformed by 33.51% the S&P500.

Hs Management Partners Llc increased its stake in Hershey Co (HSY) by 11.87% based on its latest 2017Q4 regulatory filing with the SEC. Hs Management Partners Llc bought 103,475 shares as the company’s stock declined 14.93% with the market. The institutional investor held 975,150 shares of the specialty foods company at the end of 2017Q4, valued at $110.69M, up from 871,675 at the end of the previous reported quarter. Hs Management Partners Llc who had been investing in Hershey Co for a number of months, seems to be bullish on the $19.32 billion market cap company. The stock decreased 0.14% or $0.13 during the last trading session, reaching $92.33. About 291,920 shares traded. The Hershey Company (NYSE:HSY) has declined 9.67% since May 14, 2017 and is downtrending. It has underperformed by 21.22% the S&P500.

Among 4 analysts covering Idera Pharma (NASDAQ:IDRA), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Idera Pharma had 8 analyst reports since January 6, 2016 according to SRatingsIntel. Wedbush maintained it with “Outperform” rating and $6 target in Wednesday, February 1 report. The company was maintained on Friday, March 9 by H.C. Wainwright. Wedbush initiated the stock with “Outperform” rating in Wednesday, January 6 report. The stock has “Buy” rating by Piper Jaffray on Monday, September 11. The firm earned “Buy” rating on Thursday, November 9 by Piper Jaffray. The firm has “Buy” rating by H.C. Wainwright given on Thursday, November 16.

Since December 13, 2017, it had 0 insider purchases, and 2 insider sales for $5.00 million activity.

Sabby Management Llc, which manages about $835.79M and $1.10B US Long portfolio, decreased its stake in Abbvie Inc (Call) by 10,650 shares to 25 shares, valued at $242,000 in 2017Q4, according to the filing. It also reduced its holding in Halozyme Therapeutics Inc (Call) by 8,087 shares in the quarter, leaving it with 4,950 shares, and cut its stake in Vertex Pharmaceuticals Inc (Put).

Investors sentiment increased to 3.89 in 2017 Q4. Its up 2.53, from 1.36 in 2017Q3. It increased, as 5 investors sold IDRA shares while 13 reduced holdings. 35 funds opened positions while 35 raised stakes. 142.24 million shares or 202.82% more from 46.97 million shares in 2017Q3 were reported. Bancshares Of Mellon reported 446,053 shares. The Nebraska-based Ameritas Investment Inc has invested 0% in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA). Minnesota-based Us Fincl Bank De has invested 0% in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA). Illinois-based Alyeska Grp Ltd Partnership has invested 0.01% in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA). Moreover, Lau Ltd Liability has 0.03% invested in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA). Credit Suisse Ag holds 40,622 shares. State Street stated it has 0% in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA). 19,753 were reported by Parametric Portfolio Assoc Limited Com. Creative Planning has 37,100 shares for 0% of their portfolio. Vanguard holds 0% or 6.61M shares in its portfolio. Susquehanna Group Incorporated Ltd Liability Partnership has invested 0% in Idera Pharmaceuticals, Inc. (NASDAQ:IDRA). 483,773 are held by Stanley. State Common Retirement Fund reported 0% stake. Guggenheim Lc reported 38,749 shares stake. Metropolitan Life Ins Ny invested in 22,587 shares.

Since January 26, 2018, it had 0 insider purchases, and 1 insider sale for $44,620 activity.

Investors sentiment increased to 1.13 in 2017 Q4. Its up 0.07, from 1.06 in 2017Q3. It improved, as 49 investors sold HSY shares while 191 reduced holdings. 78 funds opened positions while 193 raised stakes. 107.20 million shares or 0.23% more from 106.96 million shares in 2017Q3 were reported. Amalgamated Comml Bank has 0.06% invested in The Hershey Company (NYSE:HSY) for 18,123 shares. Nelson Van Denburg And Campbell Wealth Management Group Inc Ltd Liability Com has invested 0.07% in The Hershey Company (NYSE:HSY). State Street Corporation has 0.06% invested in The Hershey Company (NYSE:HSY). Jp Marvel Investment Advisors Ltd Company has 0.28% invested in The Hershey Company (NYSE:HSY) for 8,000 shares. Mitsubishi Ufj & owns 337,993 shares or 0.07% of their US portfolio. Cwm Limited Liability Company reported 0% stake. Jnba Fincl Advsr has 1,776 shares. Orrstown Financial Services invested 0.32% of its portfolio in The Hershey Company (NYSE:HSY). Acadian Asset Management has invested 0% of its portfolio in The Hershey Company (NYSE:HSY). Highstreet Asset Mngmt Inc holds 0.11% in The Hershey Company (NYSE:HSY) or 15,832 shares. Virginia Retirement Sys Et Al has 118,900 shares for 0.16% of their portfolio. Aperio Gru Limited Liability Company holds 0.08% or 130,697 shares in its portfolio. Commonwealth Of Pennsylvania School Empls Retrmt, a Pennsylvania-based fund reported 12,619 shares. 2,255 were reported by Tarbox Family Office Inc. Ballentine Prtn Limited holds 2,594 shares or 0.02% of its portfolio.

Hs Management Partners Llc, which manages about $2.39B and $3.26B US Long portfolio, decreased its stake in Alphabet Inc by 10,973 shares to 164,283 shares, valued at $171.91 million in 2017Q4, according to the filing. It also reduced its holding in Lululemon Athletica Inc (NASDAQ:LULU) by 672,450 shares in the quarter, leaving it with 2.09M shares, and cut its stake in Wal (NYSE:WMT).

Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>